Stay updated on Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.6.4 has been added and Revision: v3.6.3 removed, indicating a minor version update to the page's release notes/metadata. This update updates the version label on the page to reflect a new release and may accompany small UI or data adjustments.
    Difference
    0.0%
    Check dated 2026-07-23T10:25:15.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new publication related to the study has been added to Publications (Telisotuzumab Vedotin in c-Met+ NSCLC), and the page shows a new revision (v3.6.3) with the older version (v3.6.1) removed, indicating an updated study record.
    Difference
    0.0%
    Check dated 2026-07-02T05:27:02.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.1, representing a minor publication release of the page. No content changes are indicated by the change data.
    Difference
    0.0%
    Check dated 2026-06-25T04:59:07.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Recruitment is now shown as closed for this study, and new navigation links for How to Read a Study Record, Common Questions, and How to Join a Study have been added. There are also minor formatting tweaks to the Intervention/Treatment heading and to the revision notes.
    Difference
    0.1%
    Check dated 2026-06-10T22:08:35.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Revision version updated from v3.5.4 to v3.5.5, reflecting a minor update to the page's revision tracking.
    Difference
    0.0%
    Check dated 2026-06-03T17:30:23.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Expanded access status on the study page changed from Available (v3.5.3) to Temporarily not available (v3.5.4). This reflects that expanded access is not currently available outside the trial.
    Difference
    0.0%
    Check dated 2026-05-20T07:31:36.000Z thumbnail image

Stay in the know with updates to Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telisotuzumab Vedotin in c-Met+ NSCLC Clinical Trial page.